Alfasigma is an Italian pharmaceutical company headquartered in Bologna, Italy. The company has a rich history that dates back to 1961 when it was founded as a result of the merger of two famous Italian pharmaceutical companies, Alfa Wassermann and Sigma-Tau. These two companies brought together their expertise and resources to create a dynamic and innovative pharmaceutical company with a global reach.

The headquarters of Alfasigma are located in Bologna, Italy. This state-of-the-art facility serves as the center for the company's research and development activities, production, and administration. The headquarters also houses the company's top management team and serves as a hub for its global operations.

Alfasigma is primarily focused on the development, manufacture, and commercialization of pharmaceutical products. The company's main product lines include prescription drugs, over-the-counter medications, and medical devices. They have a diverse portfolio that covers various therapeutic areas including gastrointestinal diseases, central nervous system disorders, and urological disorders.

In terms of its global operations, Alfasigma has a significant presence in several countries around the world. The company has subsidiaries and joint ventures in key markets such as the United States, Canada, Brazil, Germany, France, Spain, and China. These partnerships enable Alfasigma to tap into local markets and expand its customer base.

Alfasigma has established a strong market position both domestically and internationally. The company has experienced steady growth over the years and has consistently ranked among the top pharmaceutical companies in Italy. Its commitment to research and development, high-quality products, and strong customer relationships has helped them maintain a competitive edge in the industry.

In recent years, Alfasigma has made several notable achievements and changes to its product lineup. They have introduced innovative drugs and medical devices, expanded their distribution channels, and invested in research and development to stay at the forefront of medical advancements. As of the latest available information, Alfasigma continues to grow and thrive in the pharmaceutical industry.

The company remains committed to improving the health and well-being of people worldwide through the development of innovative and high-quality pharmaceutical products